Latest News

Risk Factors that Can Disrupt Acute Lymphoblastic Leukemia Treatment
Genetic variation can cause severe acute pancreatitis from chemotherapy in patients with acute lymphoblastic leukemia (ALL).
Vegetative area levels linked to significant decreases in diabetes, chronic illnesses, high cholesterol, and hypertension.
Obinutuzumab (Gazyva) is an engineered monoclonal antibody designed to attach to the CD20 protein.
Remicade treats rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis, and ulcerative colitis.
Lixisenatide is an investigational fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist for adults with type 2 diabetes.
Top news of the week on Specialty Pharmacy Times.
Acute exenatide administration reduces glucose production and insulin resistance in liver tissue.
Top news of the day from across the healthcare landscape.

Features

Government Advocacy in Specialty Pharmacy
Ongoing challenges in specialty pharmacy could have dire consequences, which require industry stakeholders to get involved so legislators make informed decisions.
Independent specialty pharmacies foster the development of innovative services and programs that demonstrate a patient-centric approach and an entrepreneurial business philosophy.
Long-term care pharmacies have seen significant growth among select specialty categories.
The Affordable Care Act has created a glut of patients awaiting authorization for the therapies payers have longed for.

Videos

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses the elements of an effective interdisciplinary collaborative patient management program.

Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses initiatives to optimize medication adherence.

Grant E. Knowles, vice president of business development at Ardon Health, discusses how biosimilars may impact the high cost of specialty drugs.

Marc O'Connor, chief operating officer of Curant Health, discusses how the transition to value-based care can be optimized for specialty stakeholders.

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
HCPLive
ONCLive
Targeted Oncology
Physicians' Education Resource
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2016
Intellisphere, LLC. All Rights Reserved.
 

$vacMongoViewPlus$